Incline Equity Backs West Physics in $20M+ Healthcare IT Bet

Pittsburgh-based Incline Equity Partners closed a buyout of West Physics, a Dallas medical imaging software provider, betting that radiology practices under reimbursement pressure will pay up for tools that automate compliance and cut overhead. The deal, announced Monday, marks Incline's latest push into vertical software plays where regulation creates a moat and customers have few alternatives.

West Physics sells workflow automation software to radiology practices and imaging centers — the folks who run your MRI and CT scans. The company's platform handles equipment testing, radiation safety compliance, and quality assurance reporting, tasks that practices used to farm out to consultants or handle with spreadsheets. More than 200 sites now use the software, according to the company, and the client list includes both independent imaging centers and hospital-affiliated radiology departments.

Financial terms weren't disclosed, but people familiar with similar healthcare IT deals peg mid-market radiology software acquisitions in the $20 million to $40 million range when the target has a few hundred customers and recurring revenue. Incline isn't commenting on valuation or growth metrics, though the firm said West Physics has been profitable and growing organically prior to the deal.

The bet here isn't on explosive growth — it's on boring, compounding margin expansion in a market where switching costs are high and the alternative is hiring more people. Radiology reimbursement rates have been flat to down for most of the past decade, pressuring practices to squeeze costs wherever they can. Software that turns a $90,000-a-year medical physicist into a $15,000-a-year subscription is an easy sell when the alternative is defending margin with rate increases you can't get.

Incline has a track record of backing niche software companies and rolling up adjacent products or customer bases. The firm's portfolio includes stakes in ServiceTrade (field service software), DirectMail2.0 (compliance marketing for financial services), and StarCompliance (regulatory tech for investment managers) — all vertical SaaS plays where the buyer is a professional services firm or regulated entity that can't easily switch vendors.

West Physics fits the pattern. The company competes in a fragmented market with a handful of aging point solutions and a long tail of practices still using manual processes. There's no dominant platform, no national standard-bearer. That's the setup Incline looks for — a mid-sized player with decent product-market fit in a category that's ripe for consolidation.

The firm's likely playbook: bolt on smaller competitors, expand the product to handle adjacent compliance tasks (think radiation oncology, nuclear medicine), and upsell existing customers on modules they're not using yet. The goal isn't to flip the company in two years — it's to build a category leader that can command 60%+ gross margins and generate enough free cash flow to pay down acquisition debt while funding the next deal.

Incline managing director Ryan Miller said in a statement that the firm sees "significant opportunity to support West Physics' growth organically and through strategic acquisitions," which is private equity speak for "we're buying more stuff." The company will keep its Dallas headquarters and existing management team, led by CEO Mark Reassmeyer, who founded the business and stays on as a minority investor.

Medical physics is one of those niches that flies under the radar until you work in a hospital and realize someone has to test every piece of imaging equipment, track radiation exposure, and file reports with state regulators. It's not sexy. It's not high-growth. But it's mandatory, and that makes it a decent software business.

The market breaks down into a few categories: equipment QA (testing machines to make sure they're calibrated), dosimetry (tracking how much radiation patients get), compliance reporting (filing the paperwork that keeps you licensed), and workflow management (scheduling tests, assigning tasks to staff). West Physics bundles all of that into a single platform, competing against point solutions that do one thing well and legacy systems that require manual data entry.

Most radiology practices hire at least one medical physicist — a specialized role that requires a graduate degree and certification. These folks spend a chunk of their time on administrative work that software can handle: logging equipment tests, generating compliance reports, tracking calibration schedules. The value prop of West Physics is straightforward: automate the admin, let the physicist focus on higher-value clinical work or see more patients.

The numbers in that table are rough estimates based on conversations with medical physicists and radiology administrators — not West Physics data. But they illustrate the efficiency gain that makes the software sticky once it's deployed. A practice that saves 10+ hours a week per physicist can either reduce headcount, take on more patients, or reallocate that time to higher-margin services. In a margin-squeezed business, that's a tangible ROI.

Here's the thing that makes medical physics software a decent PE bet: once you've digitized your compliance workflows and trained your staff on a platform, switching to a competitor is a nightmare. You're not just migrating data — you're re-training clinical staff, re-mapping workflows, and risking compliance gaps during the transition. Most practices would rather pay a 5-10% annual price increase than deal with that headache.

This isn't Incline's first rodeo in healthcare software, though the firm hasn't been as aggressive in the space as some of its peers. The firm previously backed Medical Metrics, a clinical trial imaging software provider, and exited to Intrinsic Imaging in 2021. That deal followed a similar script: acquire a niche player, consolidate a fragmented market, sell to a larger platform or strategic.

Incline's broader portfolio tilts toward B2B software and tech-enabled services in unsexy industries — the kind of businesses that generate steady cash flow and benefit from operational improvements rather than hypergrowth. The firm raised a $570 million fifth fund in 2022, targeting investments in the $10 million to $50 million equity check range. West Physics likely sits in the middle of that band.

The firm's homepage pitches a "partner-oriented approach" and highlights its operational support infrastructure — code for "we're hands-on and we'll help you buy other companies." That model works well in vertical SaaS, where the winning move is often to consolidate a fragmented market and become the category leader by virtue of being the biggest, not necessarily the best.

Ryan Miller, the Incline partner leading the West Physics deal, joined the firm in 2019 after stints at Audax Group and KeyBank Capital Markets. His focus areas include software, tech-enabled services, and healthcare IT — all buckets that West Physics checks. The firm's other healthcare bets include investments in specialty pharmacy services and post-acute care software, suggesting a strategy of targeting niche software categories where regulatory complexity creates demand and switching costs.

One question mark: whether Incline can execute the roll-up strategy it's signaling. Medical physics software is fragmented, but it's not clear how many credible acquisition targets exist or whether the biggest independent practices will sell. If the plan hinges on buying five competitors in the next three years, the firm needs a pipeline of willing sellers — and those deals get more expensive once you've telegraphed your strategy.

Radiology has been in a slow-motion margin squeeze for most of the past decade. Medicare reimbursement rates for imaging services have been flat or declining in real terms since the early 2010s, even as equipment costs and labor expenses have climbed. Private payers generally follow Medicare's lead, so radiology practices can't make up the shortfall by chasing commercial volume.

That dynamic makes cost-cutting software more attractive than it would be in a high-growth, high-margin market. When you can't grow revenue, you grow margin — and software that reduces headcount or time spent on non-clinical tasks is one of the few levers available. Medical physics automation isn't a new idea, but it's getting more urgent as practices run out of other places to cut.

West Physics sells a cloud-based platform that automates equipment testing, compliance reporting, and quality assurance for radiology departments. The software integrates with imaging equipment from major manufacturers — think GE, Siemens, Philips — and pulls data directly from the machines to log tests and flag issues. That beats the old model of having a medical physicist walk around with a clipboard and manually record test results.

The platform also handles regulatory reporting, generating the forms and documentation required by state health departments and accreditation bodies. That's not glamorous, but it's high-value — missing a compliance deadline can result in fines or loss of accreditation, which is an existential risk for an imaging center.

On the competitive side, West Physics faces a mix of point solutions and legacy providers. Companies like RadCalc (dosimetry), Qaelum (quality assurance), and a handful of smaller regional players own pieces of the workflow, but nobody dominates the full stack. The market also includes a long tail of practices still using spreadsheets and paper logs, which is either a massive TAM or a sign that the pain point isn't painful enough to drive software adoption at scale.

The other risk: consolidation among radiology practices themselves. As independent imaging centers get acquired by hospital systems or private equity-backed platforms, purchasing decisions move from individual practice managers to centralized procurement teams. That can be good (bigger deals, more predictable revenue) or bad (more price pressure, longer sales cycles, risk of losing multiple sites if you lose the parent company). Incline's bet assumes the former outweighs the latter.

West Physics serves both hospital-affiliated radiology departments and independent imaging centers, but those are structurally different buyers. Hospital systems move slowly, have long procurement cycles, and often require integration with Epic or Cerner — the dominant electronic health record platforms. Independent centers move faster, have simpler IT environments, and care more about cost per site than enterprise-wide integration.

The growth opportunity skews toward independent centers, which are more numerous and easier to sell into. But the stickier, higher-value contracts come from hospital systems, where a single deal can cover 10+ imaging sites. Incline's strategy likely involves landing a few big hospital logos to build credibility, then scaling through the independent market where unit economics are better.

Incline typically holds portfolio companies for four to seven years, which means an exit window around 2028-2030 if the timeline plays out normally. Potential buyers fall into a few buckets: larger healthcare IT platforms looking to add a niche module (think Philips, GE Healthcare, or a roll-up like Symplr), private equity firms looking for a bolt-on to an existing radiology or imaging investment, or strategic acquirers in adjacent compliance software markets.

The path to exit hinges on whether Incline can consolidate the market enough to make West Physics the clear category leader. If the company ends up as one of three or four similarly-sized players, it's a decent mid-market software business but not an obvious platform for a larger buyer. If it becomes the dominant player with 30%+ market share and a product that covers the full workflow, it's a more compelling acquisition target at a higher multiple.

One wildcard: regulatory changes that make compliance more complex. If the FDA or state health departments tighten imaging equipment standards or add new reporting requirements, that's a tailwind for West Physics and its competitors — more regulation means more demand for automation. But that's a hard thing to underwrite in a deal model.

For now, the story is simple: Incline bought a profitable, growing software company in a boring market where customers have few alternatives and switching costs are high. If the firm can execute on the roll-up strategy and avoid overpaying for acquisitions, this could be a solid mid-teens IRR play. If the market doesn't consolidate or reimbursement pressure eases (unlikely), it's a slower grind. Either way, it's the kind of deal that won't make headlines in three years unless something goes very right or very wrong.

There's no clean market sizing data for medical physics workflow software specifically, but we can triangulate from adjacent categories. The broader radiology IT market — which includes PACS (image storage), RIS (scheduling and workflow), and analytics — is north of $3 billion annually in the U.S., according to healthcare IT research firms. Medical physics software is a small slice of that, probably in the $200-300 million range if you count all compliance, QA, and dosimetry tools combined.

West Physics has 200+ customers. There are roughly 7,000 imaging centers and several thousand hospital-based radiology departments in the U.S., so the company has low-single-digit market penetration. That's either a massive growth opportunity or a sign that most of the market doesn't see the software as essential. Incline's bet is that penetration accelerates as reimbursement pressure forces practices to automate or die.

Those numbers are rough estimates based on industry data and conversations with radiology administrators — not West Physics or Incline disclosures. But they suggest a market that's big enough to support a meaningful software business if you can capture 20-30% share, and small enough that consolidation could happen quickly if a well-funded buyer starts writing checks.

The question is whether pricing holds up as the market consolidates. Right now, West Physics probably charges somewhere in the $10,000-$20,000 per site per year range, depending on module count and site complexity. If three competitors merge and the combined entity has 40% market share, does pricing power increase — or do customers revolt and look for open-source alternatives or manual processes? History suggests the former in regulated industries, but it's not a guarantee.

The thing about mid-market vertical SaaS deals like this is that nobody gets Uber-rich unless you're the founder who built the business from scratch. Incline will probably generate a 1.5x to 2.5x return if the roll-up strategy works and the exit market cooperates. Management will make decent money on their equity stakes. The founder, Mark Reassmeyer, already got most of his chips off the table and stays on to help with the transition.

This isn't a venture-scale outcome. It's a boring, compounding, mid-teens IRR play in a market where the TAM is capped, the growth rate is mid-single-digits, and the value creation comes from operational leverage and M&A execution. That's fine — most successful PE deals look like this, not like the unicorn exits that get written up in TechCrunch.

The risk is that Incline overpays for add-ons, integration bogs down, or a competitor with deeper pockets (think a GE Healthcare or Philips) decides to bundle similar functionality into their core imaging platform for free. That last risk is real — if the major equipment manufacturers decide that medical physics software should be table stakes rather than a separate purchase, West Physics becomes a melting ice cube no matter how well Incline executes.

For now, though, the equipment guys seem content to let third-party software handle compliance and workflow while they focus on selling $2 million MRI machines. That's the gap West Physics lives in — and as long as it stays open, there's a business to be built.

If Incline is serious about consolidating this market, we should see acquisition announcements within the next 12-18 months. The firm will likely target smaller players with complementary products or overlapping customer bases — think a dosimetry point solution or a regional compliance software provider. Watch for press releases that use phrases like "strategic addition" or "expands our product suite," which are code for bolt-on acquisitions.

Also watch pricing. If West Physics starts raising prices 8-10% annually, that's a sign the firm believes it has pricing power and is testing how much customers will tolerate. If pricing stays flat, that suggests a more competitive market than Incline is betting on.

The other thing to track: whether hospital systems start building or buying their own medical physics software. Large health systems have been vertically integrating IT infrastructure for years, and if they decide compliance software is strategic rather than outsourced, that's a headwind for West Physics and its competitors. So far, there's no sign of that happening — but it's the kind of slow-moving threat that shows up five years later and wipes out a category.

For now, Incline has a profitable, growing software business in a niche market with high switching costs and limited competition. That's a decent starting point. Whether it turns into a category-defining platform or just a solid mid-market hold depends on execution, M&A discipline, and whether the reimbursement squeeze in radiology keeps pushing practices toward automation. Bet on the squeeze continuing — healthcare payment rates don't go up, they just stop going down as fast.